EU/3/19/2139

Table of contents

About

On 26 February 2019, orphan designation (EU/3/19/2139) was granted by the European Commission to Clinical Network Services (UK) Limited, United Kingdom, for autologous adult live cultured osteoblasts for the treatment of non-traumatic osteonecrosis.

The sponsorship was transferred to Clinical Network Services (NL) B.V., the Netherlands, in March 2019.

Key facts

Active substance
Autologous adult live cultured osteoblasts
Disease / condition
Treatment of non-traumatic osteonecrosis
Date of first decision
26/02/2019
Outcome
Positive
EU designation number
EU/3/19/2139

Sponsor's contact details

Clinical Network Services (NL) B.V.
De Cuserstraat 93
1081 CN Amsterdam
Noord-Holland
The Netherlands
Tel. +31 2089 49169
E-mail: cns@clinical.net.au

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

How useful was this page?

Add your rating